Nova Eye Medical Limited
ELXMF
$0.00
-$0.10-98.10%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.10M | -1.10M | -1.17M | -1.15M | -1.76M |
| Total Depreciation and Amortization | 156.20K | 155.70K | 547.10K | 535.70K | 180.50K |
| Total Amortization of Deferred Charges | 208.70K | 208.10K | -190.60K | -186.60K | 193.90K |
| Total Other Non-Cash Items | -14.10K | -14.10K | 164.00K | 160.60K | 217.60K |
| Change in Net Operating Assets | -- | -- | -170.70K | -167.20K | -- |
| Cash from Operations | -753.50K | -751.10K | -824.10K | -807.00K | -1.17M |
| Capital Expenditure | -45.00K | -44.80K | -65.70K | -64.30K | -30.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.10K | -13.10K | -7.70K | -7.50K | -13.70K |
| Cash from Investing | -58.10K | -57.90K | -73.30K | -71.80K | -44.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -194.00K | -194.00K | -130.50K | -130.50K | -176.00K |
| Issuance of Common Stock | -- | -- | 3.08M | 3.08M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -127.30K | -126.90K | 1.89M | 1.85M | -114.70K |
| Foreign Exchange rate Adjustments | 140.80K | 140.30K | -99.00K | -96.90K | 55.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -798.10K | -795.60K | 895.90K | 877.30K | -1.27M |